4//SEC Filing
Bruns Ingmar 4
Accession 0001838041-26-000002
CIK 0001725160other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 8:34 PM ET
Size
314.6 KB
Accession
0001838041-26-000002
Insider Transaction Report
Form 4
Bruns Ingmar
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-08+365,000→ 365,000 totalExercise: $2.84Exp: 2036-01-07→ Common Stock (365,000 underlying)
Footnotes (1)
- [F1]The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001838041
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 8:34 PM ET
- Size
- 314.6 KB